PHIO PHARMACEUTICALS CORP.

PHIO ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
EFFECT Jan 28, 2025
D Jan 28, 2025
D Jan 28, 2025
D Jan 28, 2025
CORRESP Jan 27, 2025
UPLOAD Jan 24, 2025
SCHEDULE 13G Jan 23, 2025
S-1 Jan 21, 2025 S-1
SCHEDULE 13G Jan 17, 2025
8-K Jan 17, 2025 CURRENT REPORT
424B5 Jan 17, 2025 FORM 424B5
8-K Jan 15, 2025 CURRENT REPORT
424B5 Jan 15, 2025 PROSPECTUS
8-K Jan 14, 2025 CURRENT REPORT
424B5 Jan 14, 2025 PROSPECTUS
8-K Jan 13, 2025 CURRENT REPORT
D Jan 7, 2025
D Jan 3, 2025
SCHEDULE 13G Dec 27, 2024
8-K Dec 26, 2024 FORM 8-K
SCHEDULE 13G Dec 26, 2024
424B5 Dec 23, 2024 FORM 424B5
8-K Dec 20, 2024 CURRENT REPORT
424B5 Dec 20, 2024 PROSPECTUS SUPPLEMENT
8-K Dec 19, 2024 FORM 8-K
← Newer Page 5 of 36 · 883 filings Older →